Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Wolff

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
The American Journal of Medicine|March 1, 1976
Successful renal transplantation in Wegener's granulomatosisA S Fauci, J E Balow, R Brown, et al.
Annals of Surgery|August 1, 1994
Does the route of feeding modify the inflammatory response?A A Santos, M L Rodrick, D O Jacobs, et al.
Lancet (London, England)|December 7, 1991
Production of interleukin-1-receptor antagonist during experimental endotoxaemiaE V Granowitz, A A Santos, D D Poutsiaka, et al.
The American Journal of Physiology|July 1, 1994
Altered interleukin-1 and tumor necrosis factor production and secretion during pyrogenic tolerance to LPS in rabbitsG Wakabayashi, J G Cannon, J A Gelfand, et al.
Journal of Clinical Immunology|May 1, 1997
Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndromeJ G Cannon, J B Angel, L W Abad, et al.
The Journal of Infectious Diseases|March 1, 1986
Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccineE Telzak, S M Wolff, C A Dinarello, et al.
Gastroenterology|November 1, 1978
Early idiopathic hemochromatosis with absent stainable bone marrow iron storesB L Blitzer, G B Weiss, G W Osbaldiston, et al.
The New England Journal of Medicine|June 9, 1988
Detection of circulating tumor necrosis factor after endotoxin administrationH R Michie, K R Manogue, D R Spriggs, et al.
The Journal of Experimental Medicine|June 1, 1986
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1C A Dinarello, J G Cannon, S M Wolff, et al.
Cytokine|September 1, 1992
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansE V Granowitz, R Porat, J W Mier, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
The American Journal of Medicine|March 1, 1976
Successful renal transplantation in Wegener's granulomatosisA S Fauci, J E Balow, R Brown, et al.
Annals of Surgery|August 1, 1994
Does the route of feeding modify the inflammatory response?A A Santos, M L Rodrick, D O Jacobs, et al.
Lancet (London, England)|December 7, 1991
Production of interleukin-1-receptor antagonist during experimental endotoxaemiaE V Granowitz, A A Santos, D D Poutsiaka, et al.
The American Journal of Physiology|July 1, 1994
Altered interleukin-1 and tumor necrosis factor production and secretion during pyrogenic tolerance to LPS in rabbitsG Wakabayashi, J G Cannon, J A Gelfand, et al.
Journal of Clinical Immunology|May 1, 1997
Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndromeJ G Cannon, J B Angel, L W Abad, et al.
The Journal of Infectious Diseases|March 1, 1986
Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccineE Telzak, S M Wolff, C A Dinarello, et al.
Gastroenterology|November 1, 1978
Early idiopathic hemochromatosis with absent stainable bone marrow iron storesB L Blitzer, G B Weiss, G W Osbaldiston, et al.
The New England Journal of Medicine|June 9, 1988
Detection of circulating tumor necrosis factor after endotoxin administrationH R Michie, K R Manogue, D R Spriggs, et al.
The Journal of Experimental Medicine|June 1, 1986
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1C A Dinarello, J G Cannon, S M Wolff, et al.
Cytokine|September 1, 1992
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansE V Granowitz, R Porat, J W Mier, et al.
Pageof 18